R Lieberman

1.6k total citations
42 papers, 1.3k citations indexed

About

R Lieberman is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, R Lieberman has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Immunology. Recurrent topics in R Lieberman's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (10 papers) and T-cell and B-cell Immunology (6 papers). R Lieberman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (10 papers) and T-cell and B-cell Immunology (6 papers). R Lieberman collaborates with scholars based in United States, Sweden and Canada. R Lieberman's co-authors include William Humphrey, Michael Potter, E. B. Mushinski, W E Paul, Stuart Rudikoff, J. H. Stimpfling, J J Mond, Mark Vrana, W E Paul and John T. Kung and has published in prestigious journals such as Science, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

R Lieberman

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Lieberman United States 19 705 614 509 112 107 42 1.3k
Hans Hjelm Sweden 9 248 0.4× 477 0.8× 750 1.5× 77 0.7× 81 0.8× 18 1.7k
Robert A. Murgita Canada 25 1.0k 1.5× 219 0.4× 457 0.9× 144 1.3× 104 1.0× 54 1.8k
B. Gardner United Kingdom 22 315 0.4× 255 0.4× 356 0.7× 152 1.4× 547 5.1× 40 1.2k
S. C. Bansal United States 14 831 1.2× 266 0.4× 302 0.6× 118 1.1× 64 0.6× 23 1.4k
Robert Schrèk United States 21 410 0.6× 163 0.3× 351 0.7× 81 0.7× 89 0.8× 92 1.4k
Yuji Nagano Japan 6 560 0.8× 602 1.0× 844 1.7× 64 0.6× 53 0.5× 7 1.2k
Ronald B. Faanes United States 14 474 0.7× 156 0.3× 442 0.9× 46 0.4× 91 0.9× 35 1.6k
Margaret Nelson Australia 25 604 0.9× 125 0.2× 300 0.6× 88 0.8× 310 2.9× 66 1.5k
Zoltan J. Lucas United States 19 492 0.7× 99 0.2× 549 1.1× 159 1.4× 29 0.3× 54 1.3k
Mona Hansson Sweden 23 1.0k 1.4× 92 0.1× 401 0.8× 66 0.6× 370 3.5× 51 1.7k

Countries citing papers authored by R Lieberman

Since Specialization
Citations

This map shows the geographic impact of R Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Lieberman more than expected).

Fields of papers citing papers by R Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Lieberman. The network helps show where R Lieberman may publish in the future.

Co-authorship network of co-authors of R Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of R Lieberman. A scholar is included among the top collaborators of R Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Lieberman. R Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madan, Ravi A., R Lieberman, James L. Gulley, William L. Dahut, & Philip M. Arlen. (2007). Significant Prostate-Specific Antigen (PSA) Response to Low-Dose Ketoconazole in a Patient With Non-Metastatic Androgen-Independent Prostate Cancer (AIPC) and a Review of the Literature. American Journal of Therapeutics. 14(3). 310–313. 2 indexed citations
2.
Leppert, John T., Oleg Shvarts, Kelly Kawaoka, et al.. (2005). Prevention of Bladder Cancer: A Review. European Urology. 49(2). 226–234. 66 indexed citations
3.
Cook, Curtiss B., et al.. (2005). The Intelligent Dosing System: Application for Insulin Therapy and Diabetes Management. Diabetes Technology & Therapeutics. 7(1). 58–71. 11 indexed citations
4.
Cook, Curtiss B., John McMichael, Virginia G. Dunbar, & R Lieberman. (2005). Description and Preliminary Evaluation of a Multiagent Intelligent Dosing System (MAIDS™) to Manage Combination Insulin–Oral Agent Therapy in Type 2 Diabetes. Diabetes Technology & Therapeutics. 7(6). 937–947. 3 indexed citations
5.
Heath, Elisabeth I., Theodore L. DeWeese, Alan W. Partin, et al.. (2002). The Design of a Randomized, Placebo-Controlled Trial of Celecoxib in Preprostatectomy Men with Clinically Localized Adenocarcinoma of the Prostate. PubMed. 1(3). 182–187. 5 indexed citations
6.
Lieberman, R, et al.. (2001). Posterior Facet Talocalcaneal Coalition. Journal of the American Podiatric Medical Association. 91(8). 422–426. 7 indexed citations
7.
Weiner, Jonathan P., Bárbara Starfield, & R Lieberman. (1992). Johns Hopkins Ambulatory Care Groups (ACGs). A case-mix system for UR, QA and capitation adjustment.. PubMed. 6(1). 13–9. 42 indexed citations
8.
Lieberman, R, et al.. (1986). A comment on the commentary. Immunogenetics. 23(5). 311–311. 1 indexed citations
9.
Lieberman, R, Lawrence A. D'Hoostelaere, William Humphrey, Susumu Nishinarita, & Michael Potter. (1983). An allotype linked gene that is associated with a negative or very low anti-phosphorylcholine response (PC) phenotype in wild mice (CNV).. The Journal of Immunology. 131(3). 1570–1575. 3 indexed citations
10.
Lieberman, R, Stuart Rudikoff, William Humphrey, & Michael Potter. (1981). Allelic forms of anti-phosphorylcholine antibodies.. The Journal of Immunology. 126(1). 172–176. 18 indexed citations
11.
Kung, John T., S O Sharrow, Donna G. Sieckmann, R Lieberman, & W E Paul. (1981). A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody.. The Journal of Immunology. 127(3). 873–876. 84 indexed citations
12.
Bona, C, R Lieberman, J J Mond, et al.. (1978). Immune response to levan. I. Kinetics and ontogeny of anti-levan and anti-inulin antibody response and of expression of cross-reactive idiotype.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 120(4). 1436–42. 60 indexed citations
13.
Lieberman, R, et al.. (1977). Idiotypes of inulin-binding myeloma proteins localized to variable region light and heavy chains: genetic significance.. The Journal of Experimental Medicine. 146(5). 1294–1304. 21 indexed citations
14.
Mond, J J, R Lieberman, John K. Inman, Donald E. Mosier, & W E Paul. (1977). Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers.. The Journal of Experimental Medicine. 146(4). 1138–1142. 68 indexed citations
15.
Lieberman, R, Michael Potter, William Humphrey, E. B. Mushinski, & Mark Vrana. (1975). Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice.. The Journal of Experimental Medicine. 142(1). 106–119. 82 indexed citations
16.
Lieberman, R, Michael Potter, E. B. Mushinski, William Humphrey, & Stuart Rudikoff. (1974). GENETICS OF A NEW IgVH (T15 IDIOTYPE) MARKER IN THE MOUSE REGULATING NATURAL ANTIBODY TO PHOSPHORYLCHOLINE. The Journal of Experimental Medicine. 139(4). 983–1001. 206 indexed citations
17.
Lieberman, R, W E Paul, William Humphrey, & J. H. Stimpfling. (1972). H-2-LINKED IMMUNE RESPONSE (Ir) GENES. The Journal of Experimental Medicine. 136(5). 1231–1240. 102 indexed citations
18.
Lieberman, R, C Stiffel, Richard Asofsky, et al.. (1972). GENETIC FACTORS CONTROLLING ANTI-SHEEP ERYTHROCYTE ANTIBODY RESPONSE AND IMMUNOGLOBULIN SYNTHESIS IN BACKCROSS AND F2 PROGENY OF MICE GENETICALLY SELECTED FOR "HIGH" OR "LOW" ANTIBODY SYNTHESIS. The Journal of Experimental Medicine. 136(4). 790–798. 38 indexed citations
19.
Shevach, Ethan M., R. Herberman, R Lieberman, Martin Frank, & I. Green. (1972). Receptors for Immunoglobulin and Complement on Mouse Leukemias and Lymphomas. The Journal of Immunology. 108(2). 325–328. 30 indexed citations
20.
Lieberman, R, et al.. (1959). Ascites Induced in Mice by Staphylococcus. Science. 129(3351). 775–775. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Hjelm Breakdown of academic impact, for papers by Robert A. Murgita Breakdown of academic impact, for papers by B. Gardner Breakdown of academic impact, for papers by S. C. Bansal Breakdown of academic impact, for papers by Robert Schrèk Breakdown of academic impact, for papers by Yuji Nagano Breakdown of academic impact, for papers by Ronald B. Faanes Breakdown of academic impact, for papers by Margaret Nelson Breakdown of academic impact, for papers by Zoltan J. Lucas Breakdown of academic impact, for papers by Mona Hansson
Rankless by CCL
2026